Animals,
Journal Year:
2024,
Volume and Issue:
14(3), P. 409 - 409
Published: Jan. 26, 2024
This
experiment
aimed
to
investigate
the
mitigating
effect
of
CUR
on
growth
performance
and
liver
intestinal
health
broilers
fed
AFB1-contaminated
diets.
In
this
study,
320
one-day-old
healthy
male
Arbor
Acres
(AA)
were
randomly
divided
into
four
groups,
including
Control
group
(fed
basal
diet),
AFB1
diet
containing
1
mg/kg
AFB1),
AFB1+CUR
with
500
CUR),
eight
replicates
ten
animals
per
a
28
d
experimental
period.
terms
performance,
addition
significantly
improved
AFB1-induced
significant
reductions
in
final
body
weight
day
mean
daily
gain
(p
<
0.05)
increased
ratio
feed
intake
0.05).
health,
improvements
histological
lesions
occurred
compared
group,
higher
glutathione
peroxidase
(GSH-Px),
catalase
(CAT),
total
superoxide
dismutase
(T-SOD)
activities
levels
nuclear
factor
erythroid
2-related
2
(Nrf2),
Kelch-like
ECH-associated
protein
(Keap-1),
heme
oxygenase
(HO-1),
NAD(P)H
quinone
oxidoreductase
(NQO-1)
gene
expression
relative
length
ileum
0.05),
elevated
height
ileal
villi
reduced
D-Lactate
(D-LA)
diamine
oxidase
(DAO)
broiler
serum
GSH,
CAT,
T-SOD
tissues
Nrf2,
HO-1,
NQO-1
genes
group.
conclusion,
showed
protective
against
damage
intestine
caused
by
through
Nrf2
signaling
pathway,
thereby
improving
exposed
AFB1.
Nutrition Reviews,
Journal Year:
2017,
Volume and Issue:
75(9), P. 731 - 767
Published: Aug. 3, 2017
In
recent
years,
there
has
been
growing
interest
in
the
possible
use
of
nutraceuticals
to
improve
and
optimize
dyslipidemia
control
therapy.
Based
on
data
from
available
studies,
might
help
patients
obtain
theraputic
lipid
goals
reduce
cardiovascular
residual
risk.
Some
have
essential
lipid-lowering
properties
confirmed
studies;
some
also
positive
effects
nonlipid
risk
factors
shown
early
markers
vascular
health
such
as
endothelial
function
pulse
wave
velocity.
However,
clinical
evidence
supporting
a
single
nutraceutical
or
combination
them
is
largely
variable
and,
for
many
nutraceuticals,
very
limited
therefore,
often
debatable.
The
purpose
this
position
paper
provide
consensus-based
recommendations
optimal
manage
who
are
still
not
statin
therapy,
therapy
but
achieved
goals,
with
intolerance.
This
statement
intended
physicians
other
healthcare
professionals
engaged
diagnosis
management
disorders,
especially
primary
care
setting.
Archives of Medical Science,
Journal Year:
2017,
Volume and Issue:
5, P. 965 - 1005
Published: Jan. 1, 2017
1.1.
Cardiovascular
disease
and
dyslipidemia:
prevalence
global
economic
impact
Cardiovascular
diseases
(CVDs)
are
the
leading
cause
of
mortality
worldwide,
reaching
31%
deaths
in
2012
[1].
In
particular,
atherosclerosis
ischemic
heart
(IHD)
main
causes
premature
death
Europe
responsible
for
42%
women
38%
men
under
75
years
old
[2].
The
impact
CVD
is
estimated
to
have
been
US
$906
billion
2015
expected
rise
by
22%
2030
[3].
also
represent
major
disability
developed
countries.
It
has
that
their
growing
burden
could
lead
a
increase
loss
disability-adjusted
life
(DALYs),
from
85
million
DALYs
1990
~150
2020,
becoming
non-psychological
lost
productivity
[4].
Several
risk
factors
contribute
etiology
development
CVD;
they
divided
into
those
modifiable
through
lifestyle
changes
or
taking
pharmacologic
treatment
(e.g.
hypertension,
smoking,
diabetes
mellitus,
hypercholesterolemia)
not
(age,
male
gender,
family
history)
[5].
Elevated
total
cholesterol
(TC)
low-density
lipoprotein
(LDL-C)
blood
concentrations
coronary
(CHD),
whereas
high
plasma
high-density
(HDL-C)
certain
conditions
considered
protective
[6].
Moreover,
LDL-C
remains
fundamental
CV
factor
(and
target
therapy)
even
when
statins
largely
used
general
population
[7].
An
examination
data
18
053
participants
aged
≥
20
who
participated
National
Health
Nutrition
Examination
Surveys
(NHANES)
1999
2006
showed
unadjusted
hypercholesterolemia
ranged
53.2%
56.1%
United
States
adults
[8].
Differences
related
gender
race
ethnicity
were
observed;
lower
rate
control
was
found
among
than
rates
having
check
being
told
about
reported
African
Americans
Mexican
whites
[8].
A
recent
report
American
Heart
Association
confirmed
only
75.7%
children
46.6%
present
targeted
TC
levels
(TC
<
170
mg/dl
200
adults,
untreated
individuals)
[9].
pattern
similar
other
Western
countries
[10,
11].
Biomedicine & Pharmacotherapy,
Journal Year:
2023,
Volume and Issue:
162, P. 114606 - 114606
Published: March 28, 2023
Cells
are
continually
exposed
to
reactive
oxygen
species
(ROS)
generated
during
cellular
metabolism.
Apoptosis,
necrosis,
and
autophagy
biological
processes
involving
a
feedback
cycle
that
causes
ROS
molecules
induce
oxidative
stress.
To
adapt
exposure,
living
cells
develop
various
defense
mechanisms
neutralize
use
as
signaling
molecule.
The
redox
networks
combine
pathways
regulate
cell
metabolism,
energy,
survival,
death.
Superoxide
dismutase
(SOD),
catalase
(CAT),
glutathione
peroxidase
(GPX)
essential
antioxidant
enzymes
required
for
scavenging
in
compartments
response
stressful
situations.
Among
the
non-enzymatic
defenses,
vitamin
C,
(GSH),
polyphenols,
carotenoids,
E,
etc.,
also
essential.
This
review
article
describes
how
produced
byproducts
of
oxidation/reduction
(redox)
antioxidants
system
is
directly
or
indirectly
engaged
ROS.
In
addition,
we
used
computational
methods
determine
comparative
profile
binding
energies
several
with
enzymes.
analysis
demonstrates
high
affinity
their
structures.
Antioxidants,
Journal Year:
2020,
Volume and Issue:
9(11), P. 1092 - 1092
Published: Nov. 6, 2020
Antioxidant
potential
is
defined
as
the
ability
to
neutralize
oxygen
free
radicals
that
are
generated
in
excess
due
environmental
influences.
The
body's
defense
mechanisms
often
require
support
preventing
effects
of
oxidative
stress.
literature
data
suggest
curcumin
has
antioxidant
activity
can
significantly
reduce
stress
levels.
aim
was
assess
impact
on
markers.PubMed
and
Embase
were
searched
from
database
inception
until
27
September
2019
for
randomized
clinical
trials
>20
patients
treated
with
supplements
placebo/no
intervention/physical
verify
curcumin.Four
studies
included
meta-analysis,
three
which
double-blind
one
single-blind.
A
total
308
participants
took
part
research.
40%
respondents
men.
average
age
27.60
±
3.79
years.
supplementation
time
67
days
dose
administered
645
mg/24
h.
Curcumin
increased
capacity
(TAC)
(SMD
=
2.696,
Z
2.003,
CI
95%,
p
0.045)
had
a
tendency
decrease
malondialdehyde
(MDA)
concentration
-1.579,
-1.714,
0.086).Pure
MDA
increase
capacity.
Nutrition Journal,
Journal Year:
2017,
Volume and Issue:
16(1)
Published: Oct. 11, 2017
Dyslipidemia
is
an
important
and
common
cardiovascular
risk
factor
in
the
general
population.
The
lipid-lowering
effects
of
turmeric
curcumin
are
unconfirmed.
We
performed
a
meta-analysis
to
assess
efficacy
safety
lowering
blood
lipids
patients
at
disease
(CVD).
A
comprehensive
literature
search
was
conducted
on
PubMed,
Embase,
Ovid,
Medline
Cochrane
Library
databases
identify
randomized
controlled
trials
(published
as
November
2016)
that
assessed
effect
lipid
levels
including
total
cholesterol
(TC),
low-density
lipoprotein
(LDL-C),
high-density
(HDL-C),
triglycerides
(TG).
Pooled
standardized
mean
difference
(SMD)
with
95%
confidence
interval
(CI)
used
effect.
analysis
included
7
eligible
studies
(649
patients).
Turmeric
significantly
reduced
serum
LDL-C
(SMD
=
−0.340,
[CI]:
−0.530
−0.150,
P
<
0.0001)
TG
−0.214,
CI:
−0.369
−0.059,
0.007)
compared
those
control
group.
These
may
be
effective
TC
metabolic
syndrome
(MetS,
SMD
−0.934,
−1.289
−0.579,
0.0001),
extract
could
possibly
have
greater
reducing
−0.584,
−0.980
−0.188,
0.004);
however,
yet
confirmed.
Serum
HDL-C
were
not
obviously
improved.
appeared
safe,
no
serious
adverse
events
reported
any
studies.
protect
CVD
through
improving
levels.
Curcumin
well-tolerated
dietary
adjunct
conventional
drugs.
Further
research
required
resolve
uncertainties
related
dosage
form,
dose
medication
frequency
curcumin.
Molecules,
Journal Year:
2019,
Volume and Issue:
24(14), P. 2527 - 2527
Published: July 10, 2019
Many
chemotherapeutic
drugs
have
been
used
for
the
treatment
of
cancer,
instance,
doxorubicin,
irinotecan,
5-fluorouracil,
cisplatin,
and
paclitaxel.
However,
effectiveness
chemotherapy
is
limited
in
cancer
therapy
due
to
drug
resistance,
therapeutic
selectivity,
undesirable
side
effects.
The
combination
therapies
with
natural
compounds
likely
increase
as
well
reduce
adverse
outcomes.
Curcumin,
a
polyphenolic
isolated
from
Nutrients,
Journal Year:
2020,
Volume and Issue:
12(9), P. 2499 - 2499
Published: Aug. 19, 2020
Curcumin,
a
lipophilic
polyphenol
contained
in
the
rhizome
of
Curcuma
longa
(turmeric),
has
been
used
for
centuries
traditional
Asian
medicine,
and
nowadays
it
is
widely
food
as
dietary
spice
worldwide.
It
received
considerable
attention
its
pharmacological
activities,
which
appear
to
act
primarily
through
anti-inflammatory
antioxidant
mechanisms.
For
this
reason,
proposed
tool
management
many
diseases,
among
are
gastrointestinal
neurological
diabetes,
several
types
cancer.
However,
pharmacology
curcumin
remains
be
elucidated;
indeed,
discrepancy
exists
between
well-documented
vitro
vivo
activities
poor
bioavailability
chemical
instability
that
should
limit
any
therapeutic
effect.
Recently,
hypothesized
could
exert
direct
regulative
effects
tract,
where
high
concentrations
have
detected
after
oral
administration.
Consequently,
might
directly
exerts
regulatory
on
gut
microbiota,
thus
explaining
paradox
low
systemic
wide
activities.
well
known
microbiota
important
roles
human
physiology,
composition
can
influenced
by
multitude
environmental
lifestyle
factors.
Accordingly,
perturbations
microbiome
profile
or
dysbiosis
key
role
disease
progression.
Interestingly,
metabolites
shown
influence
microbiota.
worth
noting
from
interaction
two
different
phenomena
arise:
regulation
intestinal
microflora
biotransformation
both
them
potentially
crucial
activity.
This
review
summarizes
most
recent
studies
topic,
highlighting
strong
connection
with
final
aim
adding
new
insight
into
potential
mechanisms
effects.